日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Investigating the Potential of Propranolol as an Anti-Tumor Agent in Colorectal Cancer Cell Lines.

研究普萘洛尔作为结直肠癌细胞系抗肿瘤药物的潜力

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26157513
Alzahrani Shiekhah Mohammad, Al Doghaither Huda Abdulaziz, Alkhatabi Hind Ali, Basabrain Mohammad Abdullah, Pushparaj Peter Natesan
肿瘤
肠癌
发表日期：2025
文献求助 收藏

A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications

对心血管疾病药物遗传学研究进展及其对临床影响的叙述性综述

期刊:npj Genomic Medicine
影响因子:4.8
doi:10.1038/s41525-025-00511-6
Shorbaji, Ayat; Pushparaj, Peter Natesan; Al-Ghafari, Ayat B; Mira, Loubna Siraj; Basabrain, Mohammad Abdullah; Naseer, Muhammad Imran; Ahmed, Farid; Abu-Elmagd, Muhammad; Rasool, Mahmood; Bakhashab, Sherin
心血管疾病
心血管
发表日期：2025
文献求助 收藏

Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy.

普萘洛尔和卡培他滨对诱导人类结直肠癌细胞铁死亡的协同作用：在癌症治疗中的潜在意义

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17091470
Alzahrani Shiekhah Mohammad, Al Doghaither Huda Abdulaziz, Alkhatabi Hind Ali, Basabrain Mohammad Abdullah, Pushparaj Peter Natesan
细胞生物学
肠癌
Human
铁死亡
发表日期：2025
文献求助 收藏

Current genetic models for studying congenital heart diseases: Advantages and disadvantages

目前用于研究先天性心脏病的遗传模型：优势和劣势

期刊:Bioinformation
影响因子:
doi:10.6026/973206300200415
Shorbaji, Ayat; Pushparaj, Peter Natesan; Bakhashab, Sherin; Al-Ghafari, Ayat B; Al-Rasheed, Rana R; Siraj Mira, Loubna; Basabrain, Mohammad Abdullah; Alsulami, Majed; Abu Zeid, Isam M; Naseer, Muhammad Imran; Rasool, Mahmood
心脏病
心血管
发表日期：2024
文献求助 收藏